logo

Altimmune Inc. (ALT)



Trade ALT now with
  Date
  Headline
12/21/2017 8:02:47 AM Altimmune Announces Positive Initial Data From HepTcell Phase 1 Study
12/11/2017 8:07:19 AM Altimmune Submits IND Application To FDA For Next Generation Anthrax Vaccine NasoShield
8/21/2017 8:04:18 AM Altimmune Submits IND Application For NasoVAX In Preparation For Phase 2 Trial
  
 
>